• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INTEGRA (800) HBA1CDX GEN 2; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INTEGRA (800) HBA1CDX GEN 2; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 04528123160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/04/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
The customer stated that from (b)(6) 2017, they had been having trouble keeping quality controls in range for the a1c-2 tina-quant hemoglobin a1c gen.2 (hba1c) test on the cobas integra 800 (i800).The customer tried calibrating and using fresh controls, but the issue was not resolved.The customer also mentioned that they received a complaint from a doctor stating that there were issues with an unspecified number of patient results that were reported outside of the laboratory.Patients were being diagnosed incorrectly for diabetes.The customer could not provide specific patient data, but stated that results for approximately 40 samples needed to be corrected because the difference in initial and repeat values was 0.8 - 1.0 %.No patients were treated based on erroneous results.The patients were not adversely affected.The i800 analyzer serial number was (b)(4).The customer stated that the issue was caused by an operator handling issue.The reagent, calibrator, and deproteinizer were incorrectly handled by the operator and control ranges were incorrect.There were no issues with the analyzer.No further details were provided.The customer stated that the issue is now resolved.
 
Manufacturer Narrative
The issue was determined to be caused by the incorrect handling of the reagent, calibrator, deproteinizer, and control material.There was no issue with the analyzer or performance of the materials.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INTEGRA (800) HBA1CDX GEN 2
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7199166
MDR Text Key98012433
Report Number1823260-2018-00153
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121291
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Catalogue Number04528123160
Device Lot Number25531601
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-